Search Results - "Tomaras GD"

A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.

Authors: Spearman P Lally MA Elizaga M et al.

Source: Journal of Infectious Diseases. 2011, Vol. 203 Issue 8, p1165-1173. 9p.

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

Authors: Goepfert PA Elizaga ML Sato A et al.

Source: Journal of Infectious Diseases. Mar2011, Vol. 203 Issue 5, p610-619. 10p.

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.

Authors: Johnson DC McFarland EJ Muresan P et al.

Source: Journal of Infectious Diseases. 12/15/2005, Vol. 192 Issue 12, p2129-2133. 5p.

URL: 19007810

High-dose recombinant canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.

Authors: Goepfert PA Horton H McElrath MJ et al.

Source: Journal of Infectious Diseases. 10/1/2005, Vol. 192 Issue 7, p1249-1259. 11p.

URL: 18331147

Early rise in nasal secretory IgA associated with shorter duration of SARS-CoV-2 virus shedding in an acute infection cohort.

Authors: Brackett C Zhang L Do BTN et al.

Source: Frontiers in immunology [Front Immunol] 2026 Feb 25; Vol. 17, pp. 1722585. Date of Electronic Publication: 2026 Feb 25 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine.

Authors: Stokdyk K Sahoo A Gangadhara S et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jan 21; Vol. 16, pp. 1706958. Date of Electronic Publication: 2026 Jan 21 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials.

Authors: Moodie Z Li SS Giorgi EE et al.

Source: Emerging microbes & infections [Emerg Microbes Infect] 2025 Dec; Vol. 14 (1), pp. 2485317. Date of Electronic Publication: 2025 Apr 07.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE

Candidate correlates of protection in the HVTN505 HIV-1 vaccine efficacy trial identified by positive-unlabeled learning.

Authors: Xu S Hudson A Janes HE et al.

Source: PLoS computational biology [PLoS Comput Biol] 2025 Nov 26; Vol. 21 (11), pp. e1013705. Date of Electronic Publication: 2025 Nov 26 (Print Publication: 2025).

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE

HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trial.

Authors: Reiss EIMM van der Straten K Graus LTM et al.

Source: Nature communications [Nat Commun] 2025 Nov 21; Vol. 16 (1), pp. 10250. Date of Electronic Publication: 2025 Nov 21.

Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Authors: Mkhize NN Zhang B Brackett C et al.

Corporate Authors: Mkhize NN Zhang B Brackett C et al.

Source: Nature communications [Nat Commun] 2025 Oct 06; Vol. 16 (1), pp. 8876. Date of Electronic Publication: 2025 Oct 06.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

Authors: Levy Y Moog C Wiedemann A et al.

Corporate Authors: Levy Y Moog C Wiedemann A et al.

Source: Scientific reports [Sci Rep] 2026 May 29. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

Authors: Kobie JJ Williams WB Hahn WO et al.

Corporate Authors: Kobie JJ Williams WB Hahn WO et al.

Source: MedRxiv : the preprint server for health sciences [medRxiv] 2026 May 27. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Authors: Lee MJ Cherrill LR Zacharopoulou P et al.

Corporate Authors: Lee MJ Cherrill LR Zacharopoulou P et al.

Source: The lancet. HIV [Lancet HIV] 2026 May 27. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial.

Authors: Mahomed S Paez CA Huang Y et al.

Corporate Authors: Mahomed S Paez CA Huang Y et al.

Source: The lancet. HIV [Lancet HIV] 2026 May 11. Date of Electronic Publication: 2026 May 11.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein.

Authors: De Rosa SC Gravett RM Hahn WO et al.

Corporate Authors: De Rosa SC Gravett RM Hahn WO et al.

Source: Vaccine [Vaccine] 2026 Apr 19; Vol. 79, pp. 128487. Date of Electronic Publication: 2026 Mar 21.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300).

Authors: Walsh SR Hahn WO Williams WB et al.

Corporate Authors: Walsh SR Hahn WO Williams WB et al.

Source: MedRxiv : the preprint server for health sciences [medRxiv] 2026 Apr 03. Date of Electronic Publication: 2026 Apr 03.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Precise targeting of HIV broadly neutralizing antibody precursors in humans.

Authors: Caniels TG Prabhakaran M Ozorowski G et al.

Source: Science (New York, N.Y.) [Science] 2025 Jul 31; Vol. 389 (6759), pp. eadv5572. Date of Electronic Publication: 2025 Jul 31.

Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

Authors: Parks KR Moodie Z Allen MA et al.

Source: Science translational medicine [Sci Transl Med] 2025 Jul 30; Vol. 17 (809), pp. eady6831. Date of Electronic Publication: 2025 Jul 30.

Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines.

Authors: Ackerley CG Edupuganti S Yu C et al.

Source: Frontiers in immunology [Front Immunol] 2025 May 14; Vol. 16, pp. 1557009. Date of Electronic Publication: 2025 May 14 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines.

Authors: Wilson GJ Church LWP Kelley CF et al.

Source: The Journal of infectious diseases [J Infect Dis] 2025 Apr 15; Vol. 231 (4), pp. e764-e769.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE